ImmuPharma PLC (IMM) — Long-term Investment Intensity
ImmuPharma PLC (IMM) has a Long-term Investment Intensity of 25.0% as of June 2019. Long-term investments of GBX2.00 Million represent 25.0% of total assets of GBX8.00 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See IMM total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ImmuPharma PLC Long-term Investment Intensity (2018–2018)
This chart shows how ImmuPharma PLC's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 25.0%, reflecting long-term investments of GBX2.00 Million against total assets of GBX8.00 Million GBX. Also explore total assets of ImmuPharma PLC for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for ImmuPharma PLC (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for ImmuPharma PLC from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see IMM stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 23.1% | GBX2.00 Million | GBX8.66 Million | — |